{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:23Z","timestamp":1792783343157,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuxi Taihu Lake Talent Plan, Supports for Leading Talents in Medical and Health Profession","award":["2020THRC-DJ-SNW"],"award-info":[{"award-number":["2020THRC-DJ-SNW"]}]},{"name":"Wuxi Health Care Commission Young and Middle-aged Top Talent Grant Program","award":["HB2023012"],"award-info":[{"award-number":["HB2023012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is a prevalent and refractory type of brain tumor. Over the past two decades, there have been minimal advancements in GBM therapy. The current standard treatment involves surgical excision followed by radiation and chemotherapy. Compared to other tumors, GBM is more challenging to treat due to the presence of glioma stem-like cells (GSCs) and the blood\u2013brain barrier, resulting in an extremely low survival rate. Mitochondria play a critical role in tumor respiration, metabolism, and multiple signaling pathways involved in tumor formation, progression, and cell apoptosis. Consequently, mitochondria represent promising targets for developing novel anticancer agents, including those targeting oxidative phosphorylation, reactive oxygen species (ROS), mitochondrial transfer, and mitophagy. This review outlines the mitochondrial-related therapeutic targets in GBM, highlighting the potential of mitochondria as a target for GBM treatment.<\/jats:p>","DOI":"10.1007\/s12672-025-01891-y","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T13:23:51Z","timestamp":1739107431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The promise of mitochondria in the treatment of glioblastoma: a brief review"],"prefix":"10.1007","volume":"16","author":[{"given":"Zhuo","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"N Louis","year":"2007","unstructured":"Louis N, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97\u2013109.","journal-title":"Acta Neuropathol"},{"key":"1891_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","volume":"41","author":"G Alzial","year":"2022","unstructured":"Alzial G, Renoult O, Paris F, Gratas C, Clavreul A, Pecqueur C. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene. 2022;41:613\u201321.","journal-title":"Oncogene"},{"key":"1891_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/jnci\/djq187","volume":"102","author":"ZJ Reitman","year":"2010","unstructured":"Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst. 2010;102:932\u201341.","journal-title":"J Natl Cancer Inst"},{"issue":"2022","key":"1891_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol. 2022;8(2022):1493\u2013501.","journal-title":"JAMA Oncol"},{"key":"1891_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"1891_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41:142.","journal-title":"J Exp Clin Cancer Res"},{"key":"1891_CR7","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/cancers14215377","volume":"14","author":"K Szklener","year":"2022","unstructured":"Szklener K, Mazurek M, Wieteska M, Wac\u0142awska M, Bilski M, Ma\u0144dziuk S. New directions in the therapy of glioblastoma. Cancers. 2022;14:5377.","journal-title":"Cancers"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 2019;21:v1\u2013100.","journal-title":"Neuro Oncol"},{"key":"1891_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756\u201360.","journal-title":"Nature"},{"key":"1891_CR10","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/cancers14153698","volume":"14","author":"Z Fekrirad","year":"2022","unstructured":"Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, Arefian E, Ghavami S. Immunology meets bioengineering: improving the effectiveness of glioblastoma immunotherapy. Cancers. 2022;14:3698.","journal-title":"Cancers"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fonc.2018.00462","volume":"8","author":"BG Harder","year":"2018","unstructured":"Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, Loftus JC, Tran NL. Developments in blood\u2013brain barrier penetrance and drug repurposing for improved treatment of glioblastoma. Front Oncol. 2018;8:462.","journal-title":"Front Oncol"},{"key":"1891_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suv\u00e0 ML, Regev A, Bernstein BE. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401.","journal-title":"Science"},{"key":"1891_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fonc.2019.00963","volume":"9","author":"OG Taylor","year":"2019","unstructured":"Taylor OG, Brzozowski JS, Skelding KA. Glioblastoma multiforme: an overview of emerging therapeutic targets. Front Oncol. 2019;9:963.","journal-title":"Front Oncol"},{"key":"1891_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","volume":"82","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007;82:81\u20133.","journal-title":"J Neurooncol"},{"key":"1891_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"1891_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrc3185","volume":"12","author":"D Fu","year":"2012","unstructured":"Fu D, Calvo JA, Samson LD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 2012;12:104\u201320.","journal-title":"Nat Rev Cancer"},{"key":"1891_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.dnarep.2007.03.013","volume":"6","author":"FV Jacinto","year":"2007","unstructured":"Jacinto FV, Esteller M. MGMT hypermethylation: a prognostic foe, a predictive friend. DNA Repair. 2007;6:1155\u201360.","journal-title":"DNA Repair"},{"key":"1891_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dnarep.2015.11.019","volume":"38","author":"Z Li","year":"2016","unstructured":"Li Z, Pearlman AH, Hsieh P. DNA mismatch repair and the DNA damage response. DNA Repair. 2016;38:94\u2013101.","journal-title":"DNA Repair"},{"key":"1891_CR19","doi-asserted-by":"publisher","first-page":"343re2","DOI":"10.1126\/scitranslmed.aaf6086","volume":"8","author":"A Carpentier","year":"2016","unstructured":"Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, Karachi C, Leclercq D, Lafon C, Chapelon JY, Capelle L, Cornu P, Sanson M, Hoang-Xuan K, Delattre JY, Idbaih A. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016;8:343re2.","journal-title":"Sci Transl Med"},{"key":"1891_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12951-022-01584-6","volume":"20","author":"X Guo","year":"2022","unstructured":"Guo X, Sui R, Piao H. Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma. J Nanobiotechnol. 2022;20:383.","journal-title":"J Nanobiotechnol"},{"key":"1891_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v15020547","volume":"15","author":"A Hamad","year":"2023","unstructured":"Hamad A, Yusubalieva GM, Baklaushev VP, Chumakov PM, Lipatova AV. Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies. Viruses. 2023;15:547.","journal-title":"Viruses"},{"key":"1891_CR22","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","volume":"25","author":"A Idbaih","year":"2019","unstructured":"Idbaih A, Canney M, Belin L, Desseaux C, Vignot A, Bouchoux G, Asquier N, Law-Ye B, Leclercq D, Bissery A, De Rycke Y, Trosch C, Capelle L, Sanson M, Hoang-Xuan K, Dehais C, Houillier C, Laigle-Donadey F, Mathon B, Andr\u00e9 A, Lafon C, Chapelon JY, Delattre JY, Carpentier A. Safety and feasibility of repeated and transient blood\u2013brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin Cancer Res. 2019;25:3793\u2013801.","journal-title":"Clin Cancer Res"},{"key":"1891_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15:422\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"1891_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag2942","volume":"8","author":"D Mathios","year":"2016","unstructured":"Mathios D, Kim JE, Mangraviti A, Phallen J, Park CK, Jackson CM, Garzon-Muvdi T, Kim E, Theodros D, Polanczyk M, Martin AM, Suk I, Ye X, Tyler B, Bettegowda C, Brem H, Pardoll DM, Lim M. Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. Sci Transl Med. 2016;8: 370ra180.","journal-title":"Sci Transl Med"},{"key":"1891_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","volume":"21","author":"M Saxena","year":"2021","unstructured":"Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21:360\u201378.","journal-title":"Nat Rev Cancer"},{"key":"1891_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1042\/bst0311095","volume":"31","author":"PR Rich","year":"2003","unstructured":"Rich PR. The molecular machinery of Keilin\u2019s respiratory chain. Biochem Soc Trans. 2003;31:1095\u2013105.","journal-title":"Biochem Soc Trans"},{"key":"1891_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1749-6632.2009.05039.x","volume":"1177","author":"F Weinberg","year":"2009","unstructured":"Weinberg F, Chandel NS. Mitochondrial metabolism and cancer. Ann N Y Acad Sci. 2009;1177:66\u201373.","journal-title":"Ann N Y Acad Sci"},{"key":"1891_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"274","author":"R Moreno-S\u00e1nchez","year":"2007","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393\u2013418.","journal-title":"FEBS J"},{"key":"1891_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-8722-6-19","volume":"6","author":"X Li","year":"2013","unstructured":"Li X, Fang P, Mai J, Choi ET, Wang H, Yang XF. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013;6:19.","journal-title":"J Hematol Oncol"},{"key":"1891_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1006\/abbi.1993.1452","volume":"305","author":"I Hanukoglu","year":"1993","unstructured":"Hanukoglu I, Rapoport R, Weiner L, Sklan D. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system. Arch Biochem Biophys. 1993;305:489\u201398.","journal-title":"Arch Biochem Biophys"},{"key":"1891_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/03602530600570040","volume":"38","author":"I Hanukoglu","year":"2006","unstructured":"Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev. 2006;38:171\u201396.","journal-title":"Drug Metab Rev"},{"key":"1891_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1126\/science.275.5306.1649","volume":"275","author":"K Irani","year":"1997","unstructured":"Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997;275:1649\u201352.","journal-title":"Science"},{"key":"1891_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ncb1106-1213","volume":"8","author":"MR Ramsey","year":"2006","unstructured":"Ramsey MR, Sharpless NE. ROS as a tumour suppressor? Nat Cell Biol. 2006;8:1213\u20135.","journal-title":"Nat Cell Biol"},{"key":"1891_CR34","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ncb1491","volume":"8","author":"A Takahashi","year":"2006","unstructured":"Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol. 2006;8:1291\u20137.","journal-title":"Nat Cell Biol"},{"key":"1891_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updates. 2004;7:97\u2013110.","journal-title":"Drug Resist Updates"},{"key":"1891_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"1891_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1089\/ars.2011.4414","volume":"16","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal. 2012;16:1295\u2013322.","journal-title":"Antioxid Redox Signal"},{"key":"1891_CR38","first-page":"26","volume":"5","author":"M Pollycove","year":"2006","unstructured":"Pollycove M. Radiobiological basis of low-dose irradiation in prevention and therapy of cancer. Dose-Response. 2006;5:26\u201338.","journal-title":"Dose-Response"},{"key":"1891_CR39","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.ejca.2004.02.031","volume":"40","author":"MF Renschler","year":"2004","unstructured":"Renschler MF. The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer. 2004;40:1934\u201340.","journal-title":"Eur J Cancer"},{"key":"1891_CR40","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/foc.2006.21.6.1","volume":"21","author":"SM Toler","year":"2006","unstructured":"Toler SM, Noe D, Sharma A. Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurg Focus. 2006;21:E10.","journal-title":"Neurosurg Focus"},{"key":"1891_CR41","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang H, Zhang S, Li Y, Liu Z, Mi L, Cai Y, Wang X, Chen L, Ran H, Xiao D, Li F, Wu J, Li T, Han Q, Chen L, Pan X, Li H, Li T, He K, Li A, Zhang X, Zhou T, Xia Q, Man J. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. Nat Commun. 2021;12:3720.","journal-title":"Nat Commun"},{"key":"1891_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/1570159X14666160121115641","volume":"14","author":"L Guntuku","year":"2016","unstructured":"Guntuku L, Naidu VG, Yerra VG. Mitochondrial dysfunction in gliomas: pharmacotherapeutic potential of natural compounds. Curr Neuropharmacol. 2016;14:567\u201383.","journal-title":"Curr Neuropharmacol"},{"key":"1891_CR43","doi-asserted-by":"publisher","first-page":"1211719","DOI":"10.3389\/fphar.2023.1211719","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Xu X. Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment. Front Pharmacol. 2023;14:1211719.","journal-title":"Front Pharmacol"},{"key":"1891_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015;11:9\u201315.","journal-title":"Nat Chem Biol"},{"key":"1891_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28:265\u201380.","journal-title":"Cell Res"},{"key":"1891_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1083\/jcb.201511036","volume":"212","author":"P Mishra","year":"2016","unstructured":"Mishra P, Chan DC. Metabolic regulation of mitochondrial dynamics. J Cell Biol. 2016;212:379\u201387.","journal-title":"J Cell Biol"},{"key":"1891_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"1891_CR48","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95:912\u20139.","journal-title":"Int J Radiat Biol"},{"key":"1891_CR49","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"1891_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1891_CR51","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1074\/jbc.M110249200","volume":"277","author":"A Caricasole","year":"2002","unstructured":"Caricasole A, Bettini E, Sala C, Roncarati R, Kobayashi N, Caldara F, Goto K, Terstappen GC. Molecular cloning and characterization of the human diacylglycerol kinase beta (DGKbeta) gene: alternative splicing generates DGKbeta isotypes with different properties. J Biol Chem. 2002;277:4790\u20136.","journal-title":"J Biol Chem"},{"key":"1891_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/onc.2009.358","volume":"29","author":"RJ DeBerardinis","year":"2010","unstructured":"DeBerardinis RJ, Cheng T. Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29:313\u201324.","journal-title":"Oncogene"},{"key":"1891_CR53","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354.","journal-title":"Nat Cell Biol"},{"key":"1891_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/neuonc\/now128","volume":"19","author":"H Lin","year":"2017","unstructured":"Lin H, Patel S, Affleck VS, Wilson I, Turnbull DM, Joshi AR, Maxwell R, Stoll EA. Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro Oncol. 2017;19:43\u201354.","journal-title":"Neuro Oncol"},{"key":"1891_CR55","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.7150\/thno.53506","volume":"11","author":"JL Caniglia","year":"2021","unstructured":"Caniglia JL, Jalasutram A, Asuthkar S, Sahagun J, Park S, Ravindra A, Tsung AJ, Guda MR, Velpula KK. Beyond glucose: alternative sources of energy in glioblastoma. Theranostics. 2021;11:2048\u201357.","journal-title":"Theranostics"},{"key":"1891_CR56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/jnc.15124","volume":"156","author":"B Juraszek","year":"2021","unstructured":"Juraszek B, Czarnecka-Herok J, Na\u0142\u0119cz KA. Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5. J Neurochem. 2021;156:642\u201357.","journal-title":"J Neurochem"},{"key":"1891_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2019.07.007","volume":"30","author":"J Bi","year":"2019","unstructured":"Bi J, Mischel PS. Acyl-CoA-binding protein fuels gliomagenesis. Cell Metab. 2019;30:229\u201330.","journal-title":"Cell Metab"},{"key":"1891_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41419-023-05813-0","volume":"14","author":"C Duman","year":"2023","unstructured":"Duman C, Di Marco B, Nevedomskaya E, Ulug B, Lesche R, Christian S, Alfonso J. Targeting fatty acid oxidation via Acyl-CoA binding protein hinders glioblastoma invasion. Cell Death Dis. 2023;14:296.","journal-title":"Cell Death Dis"},{"key":"1891_CR59","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2019.04.004","volume":"30","author":"C Duman","year":"2019","unstructured":"Duman C, Yaqubi K, Hoffmann A, Acikg\u00f6z AA, Korshunov A, Bendszus M, Herold-Mende C, Liu HK, Alfonso J. Acyl-CoA-binding protein drives glioblastoma tumorigenesis by sustaining fatty acid oxidation. Cell Metab. 2019;30:274-289.e5.","journal-title":"Cell Metab"},{"key":"1891_CR60","first-page":"309","volume":"6","author":"H Alho","year":"1995","unstructured":"Alho H, Kolmer M, Harjuntausta T, Hel\u00e9n P. Increased expression of diazepam binding inhibitor in human brain tumors. Cell Growth Differ. 1995;6:309\u201314.","journal-title":"Cell Growth Differ"},{"key":"1891_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20060307","volume":"113","author":"CJ Holubarsch","year":"2007","unstructured":"Holubarsch CJ, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, Rhein S. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study. Clin Sci. 2007;113:205\u201312.","journal-title":"Clin Sci"},{"key":"1891_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2020.06.002","volume":"32","author":"X Cheng","year":"2020","unstructured":"Cheng X, Geng F, Pan M, Wu X, Zhong Y, Wang C, Tian Z, Cheng C, Zhang R, Puduvalli V, Horbinski C, Mo X, Han X, Chakravarti A, Guo D. Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress. Cell Metab. 2020;32:229-242.e8.","journal-title":"Cell Metab"},{"key":"1891_CR63","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.xcrm.2022.100880","volume":"4","author":"H Kang","year":"2023","unstructured":"Kang H, Lee H, Kim K, Shin E, Kim B, Kang J, Kim B, Lee JS, Lee JM, Youn H, Youn B. DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Cell Rep Med. 2023;4:100880.","journal-title":"Cell Rep Med"},{"key":"1891_CR64","doi-asserted-by":"publisher","first-page":"216329","DOI":"10.1016\/j.canlet.2023.216329","volume":"570","author":"M De Martino","year":"2023","unstructured":"De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa AP, Attarwala N, Chen Q, Choi SW, Rabad\u00e0n R, McIntire LBJ, Gartrell RD, Kelly JM, Laiakis EC, Vanpouille-Box C. Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma. Cancer Lett. 2023;570:216329.","journal-title":"Cancer Lett"},{"key":"1891_CR65","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136.","journal-title":"Br J Cancer"},{"key":"1891_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0100-879X2003000200002","volume":"36","author":"P Newsholme","year":"2003","unstructured":"Newsholme P, Lima MM, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, Curi R. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003;36:153\u201363.","journal-title":"Braz J Med Biol Res"},{"key":"1891_CR67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427\u201333.","journal-title":"Trends Biochem Sci"},{"key":"1891_CR68","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR69","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.122.3168.501","volume":"122","author":"H Eagle","year":"1955","unstructured":"Eagle H. Nutrition needs of mammalian cells in tissue culture. Science. 1955;122:501\u201314.","journal-title":"Science"},{"key":"1891_CR70","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1042\/bj1250757","volume":"125","author":"Z Kovacevi\u0107","year":"1971","unstructured":"Kovacevi\u0107 Z. The pathway of glutamine and glutamate oxidation in isolated mitochondria from mammalian cells. Biochem J. 1971;125:757\u201363.","journal-title":"Biochem J"},{"key":"1891_CR71","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0901-1010","volume":"7","author":"T Takano","year":"2001","unstructured":"Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med. 2001;7:1010\u20135.","journal-title":"Nat Med"},{"key":"1891_CR72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE, MacKeigan JP, Porter JA, Wang YK, Cantley LC, Finan PM, Murphy LO. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009;136:521\u201334.","journal-title":"Cell"},{"key":"1891_CR73","doi-asserted-by":"publisher","first-page":"22830","DOI":"10.3390\/ijms160922830","volume":"16","author":"L Chen","year":"2015","unstructured":"Chen L, Cui H. Targeting glutamine induces apoptosis: a cancer therapy approach. Int J Mol Sci. 2015;16:22830\u201355.","journal-title":"Int J Mol Sci"},{"key":"1891_CR74","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16:749.","journal-title":"Nat Rev Cancer"},{"key":"1891_CR75","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cancers15020531","volume":"15","author":"J De Los Santos-Jim\u00e9nez","year":"2023","unstructured":"De Los Santos-Jim\u00e9nez J, Rosales T, Ko B, Campos-Sandoval JA, Alonso FJ, M\u00e1rquez J, DeBerardinis RJ, Mat\u00e9s JM. Metabolic adjustments following glutaminase inhibition by CB-839 in glioblastoma cell lines. Cancers. 2023;15:531.","journal-title":"Cancers"},{"key":"1891_CR76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-010-1316-y","volume":"67","author":"VK Todorova","year":"2011","unstructured":"Todorova VK, Kaufmann Y, Luo S, Klimberg VS. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake. Cancer Chemother Pharmacol. 2011;67:285\u201391.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1891_CR77","doi-asserted-by":"publisher","first-page":"127511","DOI":"10.1016\/j.ijbiomac.2023.127511","volume":"253","author":"E Shin","year":"2023","unstructured":"Shin E, Kim B, Kang H, Lee H, Park J, Kang J, Park E, Jo S, Kim HY, Lee JS, Lee JM, Youn H, Youn B. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma. Int J Biol Macromol. 2023;253:127511.","journal-title":"Int J Biol Macromol"},{"key":"1891_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell. 2020;37:147\u201356.","journal-title":"Cancer Cell"},{"key":"1891_CR79","doi-asserted-by":"publisher","first-page":"113390","DOI":"10.1016\/j.biopha.2022.113390","volume":"153","author":"J Wang","year":"2022","unstructured":"Wang J, Wang W, Zhu F, Duan Q. The role of branched chain amino acids metabolic disorders in tumorigenesis and progression. Biomed Pharmacother. 2022;153:113390.","journal-title":"Biomed Pharmacother"},{"key":"1891_CR80","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm.3217","volume":"19","author":"M T\u00f6njes","year":"2013","unstructured":"T\u00f6njes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, Rolli CG, Campos B, Turcan S, Sturm D, Witt H, Chan TA, Herold-Mende C, Kemkemer R, K\u00f6nig R, Schmidt K, Hull WE, Pfister SM, Jugold M, Hutson SM, Plass C, Okun JG, Reifenberger G, Lichter P, Radlwimmer B. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med. 2013;19:901\u20138.","journal-title":"Nat Med"},{"key":"1891_CR81","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm.3263","volume":"19","author":"JR Mayers","year":"2013","unstructured":"Mayers JR, Vander Heiden MG. BCAT1 defines gliomas by IDH status. Nat Med. 2013;19:816\u20137.","journal-title":"Nat Med"},{"key":"1891_CR82","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/0008-5472.CAN-22-1619","volume":"82","author":"N Meurs","year":"2022","unstructured":"Meurs N, Nagrath D. Driving with both feet: supplementing AKG while inhibiting BCAT1 leads to synthetic lethality in GBM. Can Res. 2022;82:2354\u20136.","journal-title":"Can Res"},{"key":"1891_CR83","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-21-3868","volume":"82","author":"B Zhang","year":"2022","unstructured":"Zhang B, Peng H, Zhou M, Bao L, Wang C, Cai F, Zhang H, Wang JE, Niu Y, Chen Y, Wang Y, Hatanpaa KJ, Copland JA, DeBerardinis RJ, Wang Y, Luo W. Targeting BCAT1 combined with \u03b1-ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Can Res. 2022;82:2388\u2013402.","journal-title":"Can Res"},{"key":"1891_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1891_CR85","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.3390\/ijms24054954","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wei Y, Yuan S, Sun L. Targeting mitochondrial metabolic reprogramming as a potential approach for cancer therapy. Int J Mol Sci. 2023;24:4954.","journal-title":"Int J Mol Sci"},{"key":"1891_CR86","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1091\/mbc.e02-06-0330","volume":"13","author":"F Legros","year":"2002","unstructured":"Legros F, Lomb\u00e8s A, Frachon P, Rojo M. Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell. 2002;13:4343\u201354.","journal-title":"Mol Biol Cell"},{"key":"1891_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12017-021-08678-8","volume":"24","author":"Z Wu","year":"2022","unstructured":"Wu Z, Ho WS, Lu R. Targeting mitochondrial oxidative phosphorylation in glioblastoma therapy. NeuroMol Med. 2022;24:18\u201322.","journal-title":"NeuroMol Med"},{"key":"1891_CR88","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Y Shi","year":"2019","unstructured":"Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY, Wang Z, Xie X, Sun D, Chen YJ, Tabar V, Gutin P, Williams N, De Brabander JK, Parada LF. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature. 2019;567:341\u20136.","journal-title":"Nature"},{"key":"1891_CR89","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","volume":"14","author":"Y Zou","year":"2023","unstructured":"Zou Y, Sun Y, Wang Y, Zhang D, Yang H, Wang X, Zheng M, Shi B. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat Commun. 2023;14:4557.","journal-title":"Nat Commun"},{"key":"1891_CR90","first-page":"1490","volume":"78","author":"VG Grivennikova","year":"2013","unstructured":"Grivennikova VG, Vinogradov AD. Mitochondrial production of reactive oxygen species. Biochemistry. 2013;78:1490\u2013511.","journal-title":"Biochemistry"},{"key":"1891_CR91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335\u201344.","journal-title":"J Physiol"},{"key":"1891_CR92","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms20184407","volume":"20","author":"T Ismail","year":"2019","unstructured":"Ismail T, Kim Y, Lee H, Lee DS, Lee HS. Interplay between mitochondrial peroxiredoxins and ROS in cancer development and progression. Int J Mol Sci. 2019;20:4407.","journal-title":"Int J Mol Sci"},{"key":"1891_CR93","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/sqb.2016.81.030791","volume":"81","author":"JG Gill","year":"2016","unstructured":"Gill JG, Piskounova E, Morrison SJ. Cancer, oxidative stress, and metastasis. Cold Spring Harb Symp Quant Biol. 2016;81:163\u201375.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1891_CR94","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1158\/0008-5472.CAN-22-3445","volume":"82","author":"S Agnihotri","year":"2022","unstructured":"Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford W, Taylor MD, Zadeh G, Rutka JT. Correction: PINK1 is a negative regulator of growth and the warburg effect in glioblastoma. Can Res. 2022;82:4695.","journal-title":"Can Res"},{"key":"1891_CR95","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1073\/pnas.1003428107","volume":"107","author":"F Weinberg","year":"2010","unstructured":"Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107:8788\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR96","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ccell.2017.05.006","volume":"31","author":"D Yuan","year":"2017","unstructured":"Yuan D, Huang S, Berger E, Liu L, Gross N, Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, Weber J, \u00d6llinger R, Simonavicius N, Reisinger F, Hartmann D, Meyer R, Reich M, Seehawer M, Leone V, H\u00f6chst B, Wohlleber D, J\u00f6rs S, Prinz M, Spalding D, Protzer U, Luedde T, Terracciano L, Matter M, Longerich T, Knolle P, Ried T, Keitel V, Geisler F, Unger K, Cinnamon E, Pikarsky E, H\u00fcser N, Davis RJ, Tschaharganeh DF, Rad R, Weber A, Zender L, Haller D, Heikenwalder M. Kupffer cell-derived tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell. 2017;31:771-789.e6.","journal-title":"Cancer Cell"},{"key":"1891_CR97","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279\u201390.","journal-title":"Oncogene"},{"key":"1891_CR98","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch Int J Pathol. 2005;446:475\u201382.","journal-title":"Virchows Arch Int J Pathol"},{"key":"1891_CR99","doi-asserted-by":"publisher","first-page":"21138","DOI":"10.3390\/ijms160921138","volume":"16","author":"S Faes","year":"2015","unstructured":"Faes S, Dormond O. PI3K and AKT: unfaithful partners in cancer. Int J Mol Sci. 2015;16:21138\u201352.","journal-title":"Int J Mol Sci"},{"key":"1891_CR100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2017.11.001","volume":"120","author":"S Tilborghs","year":"2017","unstructured":"Tilborghs S, Corthouts J, Verhoeven Y, Arias D, Rolfo C, Trinh XB, van Dam PA. The role of nuclear factor-kappa B signaling in human cervical cancer. Crit Rev Oncol Hematol. 2017;120:141\u201350.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1891_CR101","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780\u20133.","journal-title":"Nature"},{"key":"1891_CR102","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/biom12060786","volume":"12","author":"LA Wengert","year":"2022","unstructured":"Wengert LA, Backe SJ, Bourboulia D, Mollapour M, Woodford MR. TRAP1 chaperones the metabolic switch in cancer. Biomolecules. 2022;12:786.","journal-title":"Biomolecules"},{"key":"1891_CR103","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-18-2558","volume":"79","author":"HK Park","year":"2019","unstructured":"Park HK, Hong JH, Oh YT, Kim SS, Yin J, Lee AJ, Chae YC, Kim JH, Park SH, Park CK, Park MJ, Park JB, Kang BH. Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells. Can Res. 2019;79:1369\u201382.","journal-title":"Can Res"},{"key":"1891_CR104","doi-asserted-by":"publisher","first-page":"13653","DOI":"10.1073\/pnas.222538099","volume":"99","author":"P Onyango","year":"2002","unstructured":"Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA. 2002;99:13653\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR105","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrm3293","volume":"13","author":"RH Houtkooper","year":"2012","unstructured":"Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13:225\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1891_CR106","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.molcel.2010.12.013","volume":"40","author":"R Tao","year":"2010","unstructured":"Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell. 2010;40:893\u2013904.","journal-title":"Mol Cell"},{"key":"1891_CR107","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.170209797","volume":"97","author":"J Smith","year":"2000","unstructured":"Smith J, Ladi E, Mayer-Proschel M, Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA. 2000;97:10032\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR108","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021;40: e104705.","journal-title":"EMBO J"},{"key":"1891_CR109","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms22083903","volume":"22","author":"L Doblado","year":"2021","unstructured":"Doblado L, Lueck C, Rey C, Samhan-Arias AK, Prieto I, Stacchiotti A, Monsalve M. Mitophagy in human diseases. Int J Mol Sci. 2021;22:3903.","journal-title":"Int J Mol Sci"},{"key":"1891_CR110","doi-asserted-by":"publisher","first-page":"215752","DOI":"10.1016\/j.canlet.2022.215752","volume":"541","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang X, Zhu W, Sui Z, Wei X, Zhang Y, Qi J, Xing Y, Wang W. TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis. Cancer Lett. 2022;541:215752.","journal-title":"Cancer Lett"},{"key":"1891_CR111","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170-r185.","journal-title":"Curr Biol"},{"key":"1891_CR112","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","volume":"78","author":"LP Poole","year":"2021","unstructured":"Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78:3817\u201351.","journal-title":"Cell Mol Life Sci"},{"key":"1891_CR113","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"1891_CR114","first-page":"240","volume":"12","author":"R Visconti","year":"2009","unstructured":"Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Devel. 2009;12:240\u20135.","journal-title":"Curr Opin Drug Discov Devel"},{"key":"1891_CR115","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010716-104908","volume":"58","author":"V Sorrentino","year":"2018","unstructured":"Sorrentino V, Menzies KJ, Auwerx J. Repairing mitochondrial dysfunction in disease. Annu Rev Pharmacol Toxicol. 2018;58:353\u201389.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1891_CR116","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/cr.2016.159","volume":"27","author":"J Liang","year":"2017","unstructured":"Liang J, Cao R, Wang X, Zhang Y, Wang P, Gao H, Li C, Yang F, Zeng R, Wei P, Li D, Li W, Yang W. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2. Cell Res. 2017;27:329\u201351.","journal-title":"Cell Res"},{"key":"1891_CR117","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/1061186X.2020.1867992","volume":"29","author":"YH Qiu","year":"2021","unstructured":"Qiu YH, Zhang TS, Wang XW, Wang MY, Zhao WX, Zhou HM, Zhang CH, Cai ML, Chen XF, Zhao WL, Shao RG. Mitochondria autophagy: a potential target for cancer therapy. J Drug Target. 2021;29:576\u201391.","journal-title":"J Drug Target"},{"key":"1891_CR118","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/cells8050493","volume":"8","author":"M Vara-Perez","year":"2019","unstructured":"Vara-Perez M, Felipe-Abrio B, Agostinis P. Mitophagy in cancer: a tale of adaptation. Cells. 2019;8:493.","journal-title":"Cells"},{"key":"1891_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402600","volume":"11","author":"C Yang","year":"2024","unstructured":"Yang C, Li Z, Tian K, Meng X, Wang X, Song D, Wang X, Xu T, Sun P, Zhong J, Song Y, Ma W, Liu Y, Yu D, Shen R, Jiang C, Cai J. LncRNA-mediated TPI1 and PKM2 promote self-renewal and chemoresistance in GBM. Adv Sci. 2024;11: e2402600.","journal-title":"Adv Sci"},{"key":"1891_CR120","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1158\/0008-5472.CAN-19-0198","volume":"79","author":"J Jung","year":"2019","unstructured":"Jung J, Zhang Y, Celiku O, Zhang W, Song H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, Park DM. Mitochondrial NIX promotes tumor survival in the hypoxic niche of glioblastoma. Can Res. 2019;79:5218\u201332.","journal-title":"Can Res"},{"key":"1891_CR121","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-020-03024-5","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang Y, Wu S, Yan Y, Hu Y, Zheng Z, Li J, Wu W. Sulforaphane-cysteine inhibited migration and invasion via enhancing mitophagosome fusion to lysosome in human glioblastoma cells. Cell Death Dis. 2020;11:819.","journal-title":"Cell Death Dis"},{"issue":"Pt 3","key":"1891_CR122","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1242\/jcs.104.3.917","volume":"104","author":"RL Morris","year":"1993","unstructured":"Morris RL, Hollenbeck PJ. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci. 1993;104(Pt 3):917\u201327.","journal-title":"J Cell Sci"},{"key":"1891_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1741-7007-11-71","volume":"11","author":"SM Rafelski","year":"2013","unstructured":"Rafelski SM. Mitochondrial network morphology: building an integrative, geometrical view. BMC Biol. 2013;11:71.","journal-title":"BMC Biol"},{"key":"1891_CR124","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41392-020-00440-z","volume":"6","author":"D Liu","year":"2021","unstructured":"Liu D, Gao Y, Liu J, Huang Y, Yin J, Feng Y, Shi L, Meloni BP, Zhang C, Zheng M, Gao J. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. 2021;6:65.","journal-title":"Signal Transduct Target Ther"},{"key":"1891_CR125","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-019-1028-z","volume":"38","author":"JC Chang","year":"2019","unstructured":"Chang JC, Chang HS, Wu YC, Cheng WL, Lin TT, Chang HJ, Kuo SJ, Chen ST, Liu CS. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer. J Exp Clin Cancer Res CR. 2019;38:30.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"1891_CR126","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1479-5876-11-94","volume":"11","author":"J Pasquier","year":"2013","unstructured":"Pasquier J, Guerrouahen BS, Al Thawadi H, Ghiabi P, Maleki M, Abu-Kaoud N, Jacob A, Mirshahi M, Galas L, Rafii S, Le Foll F, Rafii A. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med. 2013;11:94.","journal-title":"J Transl Med"},{"key":"1891_CR127","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA. 2006;103:1283\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR128","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","volume":"21","author":"AS Tan","year":"2015","unstructured":"Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, Bajzikova M, Kovarova J, Peterka M, Yan B, Pesdar EA, Sobol M, Filimonenko A, Stuart S, Vondrusova M, Kluckova K, Sachaphibulkij K, Rohlena J, Hozak P, Truksa J, Eccles D, Haupt LM, Griffiths LR, Neuzil J, Berridge MV. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015;21:81\u201394.","journal-title":"Cell Metab"},{"key":"1891_CR129","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","volume":"4","author":"DC Watson","year":"2023","unstructured":"Watson DC, Bayik D, Storevik S, Moreino SS, Sprowls SA, Han J, Augustsson MT, Lauko A, Sravya P, R\u00f8sland GV, Troike K, Tronstad KJ, Wang S, Sarnow K, Kay K, Lunavat TR, Silver DJ, Dayal S, Joseph JV, Mulkearns-Hubert E, Ystaas LAR, Deshpande G, Guyon J, Zhou Y, Magaut CR, Seder J, Neises L, Williford SE, Meiser J, Scott AJ, Sajjakulnukit P, Mears JA, Bjerkvig R, Chakraborty A, Daubon T, Cheng F, Lyssiotis CA, Wahl DR, Hjelmeland AB, Hossain JA, Miletic H, Lathia JD. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat Cancer. 2023;4:648\u201364.","journal-title":"Nat Cancer"},{"key":"1891_CR130","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms22063245","volume":"22","author":"LX Zampieri","year":"2021","unstructured":"Zampieri LX, Silva-Almeida C, Rondeau JD, Sonveaux P. Mitochondrial transfer in cancer: a comprehensive review. Int J Mol Sci. 2021;22:3245.","journal-title":"Int J Mol Sci"},{"key":"1891_CR131","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature18928","volume":"535","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, Ji X, Lo EH. Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016;535:551\u20135.","journal-title":"Nature"},{"key":"1891_CR132","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/ncomms9472","volume":"6","author":"DG Phinney","year":"2015","unstructured":"Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, Kolls J, Riches DW, Deiuliis G, Kaminski N, Boregowda SV, McKenna DH, Ortiz LA. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015;6:8472.","journal-title":"Nat Commun"},{"key":"1891_CR133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature16071","volume":"528","author":"M Osswald","year":"2015","unstructured":"Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M, Huang L, Ratliff M, Karimian Jazi K, Kurz FT, Schmenger T, Lemke D, G\u00f6mmel M, Pauli M, Liao Y, H\u00e4ring P, Pusch S, Herl V, Steinh\u00e4user C, Krunic D, Jarahian M, Miletic H, Berghoff AS, Griesbeck O, Kalamakis G, Garaschuk O, Preusser M, Weiss S, Liu H, Heiland S, Platten M, Huber PE, Kuner T, von Deimling A, Wick W, Winkler F. Brain tumour cells interconnect to a functional and resistant network. Nature. 2015;528:93\u20138.","journal-title":"Nature"},{"key":"1891_CR134","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.trecan.2020.04.012","volume":"6","author":"G Pinto","year":"2020","unstructured":"Pinto G, Brou C, Zurzolo C. Tunneling nanotubes: the fuel of tumor progression? Trends Cancer. 2020;6:874\u201388.","journal-title":"Trends Cancer"},{"key":"1891_CR135","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science. 2004;303:1007\u201310.","journal-title":"Science"},{"key":"1891_CR136","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2016.00107","volume":"4","author":"D Torralba","year":"2016","unstructured":"Torralba D, Baixauli F, S\u00e1nchez-Madrid F. Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer. Front Cell Dev Biol. 2016;4:107.","journal-title":"Front Cell Dev Biol"},{"key":"1891_CR137","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1529\/biophysj.108.131375","volume":"95","author":"P Veranic","year":"2008","unstructured":"Veranic P, Lokar M, Sch\u00fctz GJ, Weghuber J, Wieser S, H\u00e4gerstrand H, Kralj-Iglic V, Iglic A. Different types of cell-to-cell connections mediated by nanotubular structures. Biophys J. 2008;95:4416\u201325.","journal-title":"Biophys J"},{"key":"1891_CR138","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/cdd.2014.211","volume":"22","author":"X Wang","year":"2015","unstructured":"Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22:1181\u201391.","journal-title":"Cell Death Differ"},{"key":"1891_CR139","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14535","volume":"30","author":"Y Hu","year":"2024","unstructured":"Hu Y, Sun YF, Yuan H, Liu J, Chen L, Liu DH, Xu Y, Zhou XF, Ding L, Zhang ZT, Xiong LL, Xue LL, Wang TH. Vof16-miR-185-5p-GAP43 network improves the outcomes following spinal cord injury via enhancing self-repair and promoting axonal growth. CNS Neurosci Ther. 2024;30: e14535.","journal-title":"CNS Neurosci Ther"},{"key":"1891_CR140","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.7150\/thno.33100","volume":"9","author":"C Sun","year":"2019","unstructured":"Sun C, Liu X, Wang B, Wang Z, Liu Y, Di C, Si J, Li H, Wu Q, Xu D, Li J, Li G, Wang Y, Wang F, Zhang H. Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity. Theranostics. 2019;9:3595\u2013607.","journal-title":"Theranostics"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01891-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01891-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01891-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:25:06Z","timestamp":1739165106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01891-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01891-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}